Skip to product information
1 of 1

Phospho-Histone H3 (Ser28) Recombinant Rat mAb (S-6125)

Phospho-Histone H3 (Ser28) Recombinant Rat mAb (S-6125)

Catalog Number: S0B60820 Application: WB Reactivity: Hu Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rat
Antigen Phospho-Histone H3 (Ser28)
Synonyms Histone H3.1; Histone H3/a; Histone H3/b; Histone H3/c; Histone H3/d; Histone H3/f; H3FA; HIST1H3ANameH3C2 SynonymsH3FL; HIST1H3BNameH3C3 SynonymsH3FC HIST1H3CNameH3C4 SynonymsH3FB; HIST1H3DNameH3C6 SynonymsH3FD; HIST1H3EMore gene names; H3C1
Location Nucleus
Accession P68431
Clone Number S-6125
Antibody Type Rat mAb
Isotype IgG2a,k
Application WB
Reactivity Hu
Positive Sample HeLa treated with 100 ng/mL nocodazole for 16 hours
Purification Protein G
Concentration 2 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000 Hu

Background

Phospho-Histone H3 (Ser28) refers to an epigenetic mark formed by phosphorylation of serine residue 28 in the N-terminal tail of histone H3. This modification was first identified by Goto et al. in 1999 and, together with Ser10 phosphorylation, is regarded as a conserved event in mitotic chromosome condensation. In mammalian cells, Aurora-B kinase is the key enzyme catalyzing Ser28 phosphorylation, acting on condensed chromosomes from prophase through metaphase; in late G2 phase, although Aurora-B is already catalytically active, continuous action of the PP1 phosphatase keeps Ser28 phosphorylation below detectable levels until PP1 is inhibited upon entry into mitosis, when the modification accumulates markedly. Beyond its mitotic functions, Ser28 phosphorylation also participates in signal-induced transcriptional regulation in interphase cells: downstream of the MAPK pathway activated by pro-tumorigenic agents (such as UV and EGF) and oncoproteins (c-Myc, c-Jun, c-Fos), MSK1 can mediate Ser28 phosphorylation; this modification is enriched in transcriptionally active chromatin regions and preferentially marks the H3.3 variant, being associated with unstable nucleosomes and the dynamic assembly–disassembly processes of promoter regions. A 2025 study further revealed that signal-induced H3S28ph domains can override the repressive chromatin state mediated by PRC2, biophysically disrupting poly-nucleosome compaction, promoting loss of H3K27me3 and increasing activating modifications, thereby driving chromatin de-repression during immune cell fate transitions. In experimental applications, clone HTA28 is the most commonly used classical antibody clone for recognizing this modification, suitable for Western blot, immunocytochemistry, and flow cytometry, often with nocodazole-treated cells as a positive control.

Picture

Western Blot

WB result of Phospho-Histone H3 (Ser28) Recombinant Rat mAb
Primary antibody: Phospho-Histone H3 (Ser28) Recombinant Rat mAb at 1/1000 dilution
Lane 1: untreated HeLa whole cell lysate 20 μg
Lane 2: HeLa treated with 100 ng/mL nocodazole for 16 hours whole cell lysate 20 μg
Lane 3: HeLa treated with 100 ng/mL nocodazole for 16 hours whole cell lysate 20 μg (phosphatase treated membrane)
Secondary antibody: Goat Anti-Rat IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 15 kDa
Observed MW: 18 kDa